OVERLAND PARK, Kan., July 21, 2017 -- Ferrellgas Partners, L.P. (NYSE:FGP) and Ferrellgas Partners Finance Corp. announced today that they have commenced an exchange offer for up to $175 million aggregate principal amount of their 85/8% Senior Notes due 2020 (the “New Notes”) that have been registered under the Securities Act of 1933, as amended (the “Act”), for an equal amount of their outstanding 85/8% Senior Notes due 2020 (the “Old Notes”). The exchange offer will expire at 5:00 p.m. (New York City time) on August 18, 2017, unless extended.
The New Notes will have terms that are identical in all material respects to the terms of the Old Notes, except that the New Notes will be registered under the Act and will not have any of the transfer restrictions, registration rights or provisions for additional interest relating to the Old Notes. Ferrellgas will not receive any cash proceeds from the exchange offer.
This announcement is for informational purposes only and is not an offer to purchase or a solicitation of an offer to purchase any securities. The exchange offer is being made solely by the prospectus, dated July 20, 2017, with respect to the exchange offer and the related letter of transmittal. Copies of the prospectus and letter of transmittal may be obtained from the exchange agent for the exchange offer, U.S. Bank National Association, Corporate Trust Services, 111 Fillmore Avenue, St. Paul, Minnesota 55107, Attention: William G. Keenan, (800) 934-6802.
This press release does not constitute an offer to sell or the solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.
Contact: Jack Herrold, Investor Relations, 913-661-1851 Jim Saladin, Media Relations, 913-661-1833 Scott Brockelmeyer, Media Relations, 913-661-1830


Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
GLP-1 Weight Loss Pills Set to Reshape Food and Fast-Food Industry in 2025
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Italy Fines Apple €98.6 Million Over App Store Dominance
Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
BlackRock-Backed Global Ports Deal Faces Uncertainty Amid Cosco Demands
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio 



